麦澜德(688273) - 投资者关系活动记录表（2024年5月27日）

Group 1: Company Overview - Nanjing Mairande Medical Technology Co., Ltd. focuses on women's health and beauty through physical rehabilitation interventions, providing comprehensive solutions from prevention to recovery [4] - The company was selected as a champion enterprise in the eighth batch of manufacturing industry by the Ministry of Industry and Information Technology in March 2024 [4] Group 2: Product Development - In March 2024, Mairande launched the "Magnetic Electric Thermal Shadow · Smart Integration PI-ONE" pelvic floor diagnosis and treatment system, enhancing its product offerings [4][5] - The company is expanding its product line to include anti-aging solutions, integrating reproductive and facial anti-aging treatments [5] Group 3: Strategic Focus - Mairande's strategy is centered on two main directions: "more serious" and "more consumer-oriented," focusing on women's health and beauty [7] - The company aims to develop its core business in pelvic floor rehabilitation while also venturing into home medical devices and anti-aging markets [5][7] Group 4: Market Engagement - The investor relations activity involved 54 institutions and 74 participants, indicating strong interest from the investment community [2] - The company is actively responding to national policies promoting the replacement of old medical equipment, which is expected to benefit the medical device industry for 2-3 years [6] Group 5: Financial and Operational Insights - Mairande has successfully completed acquisitions, including 100% of Aotong Laser and 55% of Xiaofu Technology, to enhance its anti-aging segment [7] - The company has established a stable R&D investment strategy, focusing on product industrialization and market expansion [6][7] Group 6: Risk Management - The company emphasizes that any predictions regarding industry trends or strategic plans should not be viewed as guarantees of performance, highlighting the importance of investor awareness regarding risks [8]